Pharma's Next AI Battleground: Content Velocity & Field Execution
The European pharmaceutical market, worth €313 billion in exports and running a €194 billion trade surplus, is under structural margin pressure that isn't reversing. With patent cliffs threatening $300B+ in lost revenue, rising tariffs, and stricter regulation, brands in the sector are facing growing complexity across content compliance, field execution and commercial performance at scale.
